Hypersensitivity to antihistamines. History of agranulocytosis. Risk of urine retention related to urethral or prostate disorders, angle-closure glaucoma. Combination w/ sultopride. Infants <2 yr.
CV disorders, sudden infant death syndrome (SIDS). Patients w/ peptic ulcer, epilepsy, diabetes. Rule out possible bronchial asthma or gastroesophageal reflux prior to therapy in childn. Avoid alcohol consumption & sun exposure during treatment. Fructose intolerance, glucose or galactose malabsorption syndrome or sucrase-isomaltase deficiency. Combination w/ expectorant or mucolytic. May affect ability to drive or operate machines. Severe renal &/or hepatic insufficiency. Not to be used during 1st trimester of pregnancy & lactation. Childn 2-6 yr. Not to be used in ped <2 yr. Not recommended in childn at risk of apnea <1 yr. Elderly patients w/ orthostatic hypotension, dizziness & sedation, chronic constipation, possible benign prostate hypertrophy.
(cherry/vanilla flavour) 100 mL x 12 × 1's; (cherry/vanilla flavour) 100 mL x 50 × 1's; (cherry/vanilla flavour) 60 mL x 12 × 1's; (cherry/vanilla flavour) 60 mL x 50 × 1's; (cherry/vanilla flavour) 90 mL x 12 × 1's; (cherry/vanilla flavour) 90 mL x 50 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
